EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.B41 | gene SIRT&, quantitative RT-PCR enzyme expression analysis | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.B41 | additional information | Homo sapiens | SIRT6 deacetylates Beclin-1 in HCC cells | ? | - |
- |
|
2.3.1.B41 | NAD+ + [protein]-N6-palmitoyl-L-lysine | Homo sapiens | - |
nicotinamide + [protein]-L-lysine + 2'-O-palmitoyl-ADP ribose | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.B41 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.B41 | hepatocyte | - |
Homo sapiens | - |
2.3.1.B41 | hepatoma cell | increased SIRT6 expression in HCC, SIRT6 expression pattern and its association with HCC metastasis, overview | Homo sapiens | - |
2.3.1.B41 | HL-7702 cell | - |
Homo sapiens | - |
2.3.1.B41 | liver | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.B41 | additional information | SIRT6 deacetylates Beclin-1 in HCC cells | Homo sapiens | ? | - |
- |
|
2.3.1.B41 | NAD+ + [protein]-N6-palmitoyl-L-lysine | - |
Homo sapiens | nicotinamide + [protein]-L-lysine + 2'-O-palmitoyl-ADP ribose | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.B41 | SIRT6 | - |
Homo sapiens |
2.3.1.B41 | Sirtuin6 | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.B41 | NAD+ | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.B41 | evolution | sirtuin6 belongs to the Sirtuin family | Homo sapiens |
2.3.1.B41 | physiological function | sirtuin family members function as NAD+-dependent deacetylases that are essential for tumor metastasis and epithelial-mesenchymal transition (EMT). EMT is a pivotal mechanism involved in tumor metastasis, which is the leading cause of poor prognosis for hepatocellular carcinoma (HCC). Increased sirtuin6 expression in hepatocellular carcinoma is associated with the poor prognosis. Sirtuin6 (SIRT6) promotes the EMT of hepatocellular carcinoma by stimulating autophagic degradation of E-cadherin via the lysosomal pathway. SIRT6 deacetylates Beclin-1 in HCC cells and this event leads to the promotion of the autophagic degradation of E-cadherin. E-cadherin degradation, invasion, and migration induced by SIRT6 overexpression can be rescued by dual mutation of Beclin-1 (inhibition of acetylation), CQ (autophagy inhibitor), and knockdown of Atg7. In addition, SIRT6 promotes N-cadherin and Vimentin expression via deacetylating FOXO3a in HCC. An increased vimentin and N-cadherin expression can be observed after SIRT6 is upregulated in Hep3B and LO2 cells. In MHCC-97H cells, downregulated SIRT6 causes opposite results | Homo sapiens |